StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SPA.BR$362.00+0.56%
Fair $362.00+0.0%

SPA.BR

Spadel SA

Consumer Defensive / Beverages - Non-AlcoholicBrussels

$362.00

+2.00 (+0.56%)

Fairly Valued+0.0%Fair Value $362.00Fund rank 38/100 · Data gapFallback financials|
SA 59/C
F-Score: 7/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $40.2M · quality 81.3/100

Data gap 38/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 82/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

59/100

C

Piotroski

7/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · SPA.BRLocal privado en este navegador · Spadel SA
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.5B

P/E

29.3x

↑

EV/EBITDA

15.1x

↑

ROE

14.7%

↑

Gross Margin

42.0%

↑

Debt/Equity

0.02

↓
52-Week Range$362
$195$362

TradingView lightweight chart

SPA.BR price, volumen y niveles de valoración

Último $362.00Periodo +1516.1%
Fair value: $362.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+7.6%

FCF CAGR

+24.3%

FCF margin

9.6%

FCF / Net income

0.75x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $399.5M · net income $51.2M · FCF $38.5M

2022-FY → 2025-FY

Gross margin

42.0%+9.9% pts

Operating margin

15.4%+8.4% pts

Net margin

12.8%+8.8% pts

FCF margin

9.6%+3.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$399.5M$399.5M$357.3M$345.9M$320.8M
Net Income$51.2M$51.2M$41.0M$28.2M$12.8M
EBITDA$88.3M$88.3M$74.4M$57.5M$39.0M
EPS——9.896.803.08
Gross Margin42.0%42.0%41.8%34.9%32.1%
Operating Margin15.4%15.4%13.4%9.8%7.0%
Net Margin12.8%12.8%11.5%8.2%4.0%
Balance Sheet
Debt/Equity0.020.020.020.010.02
Current Ratio2.022.02———
Cash Flow
Free Cash Flow$38.5M$38.5M$45.0M$40.2M$20.1M
Returns
ROE14.7%14.7%13.2%10.1%5.0%
Valuation
P/E29.3429.3417.8023.0951.95
EV/EBITDA15.1215.127.879.4215.06
P/B4.314.312.352.332.58
Growth & Yield
Revenue Growth11.8%11.8%3.3%7.9%—
EPS Growth——45.4%120.8%—
Dividend Yield1.1%1.1%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +80.3%

Total return

+80.3%

Start / end P/E

n/dx → n/dx

EPS bridge

9.89 → n/d

Residual

+79.2%

EPS growthn/d
Multiple reratingn/d
Dividend+1.1%
Residual / FX / buybacks / cross-term+79.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.